Month: September 2024

“Browse 434 market data Tables and 54 Figures spread through 432 Pages and in-depth TOC on “Electronic Clinical Outcome Assessment (eCOA) Solution Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Application ((Clinical trial (Onco, Rare, Mental Health)), RWE, Registery), End User – Global Forecast to 2029”

Electronic Clinical Outcome Assessment (eCOA) Solution Market in terms of revenue was estimated to be worth $1.8 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the Electronic Clinical Outcome Assessment (eCOA) Solutions market is driven by rise in patient centricity, increase in incidences of chronic disorders, and growing acceptance of eCOA solutions by several pharmaceutical and biotechnology companies for data collection and its analysis. As eCOA helps enhance patient engagement by facilitating patient-reported outcomes. Moreover, the increase in demand for real-world evidence across may boost the market during the forecast period. But the increase in concerns about data breaches and privacy may pose a challenge to the Electronic Clinical Outcome Assessment (eCOA) Solutions market during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=87857774

Hybrid model is the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023.

Based on component, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into software, services, and wearable, mobile & other devices. The wearable, mobile & other devices segment is further categorized into bring your own device model (BYOD), Provisioned device model, and hybrid model. The hybrid model is the fastest growing in Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023 attributing to its ability to offer a balanced and flexible approach to data collection in clinical trials. The hybrid model combines elements of both Bring Your Own Device (BYOD) and Provisioned Device models, providing a versatile solution that accommodates varying preferences and trial requirements. Hybrid model gives flexibility to the participants by offering option to use their own devices or devices provided by the study, depending on their comfort and accessibility. This flexibility reduces barriers to participation, as participants can choose the mode that aligns with their technological preferences.

By application, observational studies and real-world evidence generation is the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023.

Based on application, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into clinical trials, observational studies and real-world evidence (RWE) generation, patient management and registries, and other applications. Among these the observational studies and real-world evidence generation is the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023 attributing to an increasing emphasis on real-world data’s significance in healthcare decision-making. Moreover, the segment’s growth is due to the growing acceptance of real-world evidence (RWE) by regulatory bodies, healthcare providers, and pharmaceutical companies drives. RWE is crucial for understanding a treatment’s effectiveness, safety, and overall impact on patients in everyday clinical practice.

Pharmaceuticals and biotechnology companies are the largest end users of the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023.

Based on end users, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), medtech companies, government organizations, research centers & academic institutes, hospitals & healthcare providers, and consulting service companies. The pharmaceutical and biotechnology companies dominated the eCOA solutions market in 2023 attributing to growth in adoption of eCOA solution across by companies. As the Electronic Clinical Outcome Assessment (eCOA) slutions helps in advancing clinical trials by streamlining and enhancing the accuracy of data collection. Moreover, eCOA also helps to ensure the integrity of clinical data, facilitating regulatory compliance and improving overall study quality.  For pharmaceutical and biotechnology firms, the adoption of eCOA translates into accelerated decision-making, reduced trial timelines, and enhanced patient engagement, thus these end users are dominating the market.

North America dominates the global Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023.

The Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2023, North America accounted for the largest share of the Electronic Clinical Outcome Assessment (eCOA) Solutions market. As this region is home to a significant number of pharmaceutical and biotechnology companies which are using eCOA solutions. These companies conduct extensive clinical trials, seeking efficient and accurate methods of data collection to meet rigorous regulatory standards. Moreover, the well-established healthcare infrastructure in North America, coupled with a high level of digital literacy among healthcare professionals, facilitates the seamless integration of eCOA technologies. Furthermore, the region’s leadership in research and development, coupled with substantial investments in healthcare technology, reinforces its position at the forefront of the eCOA market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=87857774

Electronic Clinical Outcome Assessment (eCOA) Solution Market Dynamics:

Drivers:

1. Growing preference of digital data collection and analysis

Restraints:

1. Lack of skilled professionals to develop & operate eCOA solutions

Opportunities:

1. Increase in number of clinical trials

Challenge:

1. Evolving Regulatory landscape and compliance requirements

Key Market Players of Electronic Clinical Outcome Assessment (eCOA) Solution Industry:

Prominent players in the Electronic Clinical Outcome Assessment (eCOA) Solutions market include include Signant Health (US), IQVIA HOLDINGS INC, (US), Oracle Corporation (US), Kayentis (France), TransPerfect (US), Obvio Health USA, Inc. (US), WCG Clinical (US), clincapture (US), Merative (US), Clario (US), Medable Inc. (US), Medidata (US), healthentia (Belgium), Veeva Systems Inc. (US), assiTek (US), Curebase Inc (US), Castor (US), EvidentIQ (Germany), Y-Prime, LLC. (US), Clinical ink (US), and ICON PUBLIC LIMITED COMPANY(Ireland).

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:

• By Supply Side: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)
• By Demand Side: Hospital Directors/VPs/Managers/Department Heads (40%), Pharma & Biopharma Company’s Product managers, Purchase Heads, etc. (35%), and Others (25%).
• By Designation: C-level Executives (31%), Director-level (25%), and Managers (44%)
• By Region: North America (45%), Europe (20%), Asia Pacific (28%), and RoW (4%)

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=87857774

Electronic Clinical Outcome Assessment (eCOA) Solution Market – Key Benefits of Buying the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing R&D expenditure for product development by medtech, and pharma-biotech companies, rising operational costs and regulatory requirements associated with clinical research studies, favorable government support and funding for clinical trials, growing prevalence of chronic diseases & subsequent increase in clinical trials, effective monitoring of clinical data, reduction in overall costs and timelines of clinical trials), restraints (lack of skilled professionals to develop and operate eCOA solutions, high implementation and maintenance cost, lack of awareness about eCOA solutions among end users), opportunities (surging eCOA adoption owing to increasing number of clinical trials in emerging economies, growing outsourcing of clinical trial processes to CROs, gradual shift from manual data interpretation to real-time data analysis, growing penetration of mobile technology in healthcare industry), and challenges (evolving regulatory landscape and compliance requirements, interoperability & integration, data security & privacy issues, resistance from traditional healthcare professionals and concerns regarding software reliability) influencing the growth of electronic clinical outcome assessment (eCOA) solutions market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the electronic clinical outcome assessment (eCOA) solutions market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of electronic clinical outcome assessment (eCOA) solutions solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the electronic clinical outcome assessment (eCOA) solutions market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the electronic clinical outcome assessment (eCOA) solutions market.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ecoa-solutions-market-87857774.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Electronic Clinical Outcome Assessment (eCOA) Solution Market worth $4.1 billion by 2029

“The healthcare interoperability solutions industry is expected to grow significantly in the near future due to the increasing demand for healthcare data exchange and integration. The industry is driven by the growing focus on patient-centric care, increasing demand for cost-effective healthcare services, advances in technology, and the need for better analytics.”

Healthcare Interoperability Solutions Market in terms of revenue was estimated to be worth $3.4 billion in 2022 and is poised to reach $6.2 billion by 2027, growing at a CAGR of 12.9% from 2022 to 2027 according to a new report by MarketsandMarkets™. Growth in this market is driven by the increasing demand for efficient and cost-effictive healthcare delivery,  government initiatives towards improving the healthcare interoperability. However, the lack of true interoperability among electric systems, financial burden and technical difficulties in building and operations are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period. The base year considered for the study is 2021, while the forecast period is 2022 to 2027.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847

By type, the services segment accounted for the largest share of the healthcare interoperability solutions market in 2021.

On the basis of type: the services segment accounted for the largest share. The large share of this segment can be attributed to the advantages offered by the services such as installation, equipment updates or traditional licensing management are not required in case of services.

The healthcare providers segment is expected to witness the highest growth rate in the healthcare interoperability solutions market, by end user, during the forecast period

Based on end user: the healthcare providers segment is expected to register the highest CAGR during the forecast period. The growing geriatric population leading to the increasing hospital admissions is contributing to the growth of this segment.

North America dominated the healthcare interoperability solutions market in 2021

North America accounted for the largest share of the healthcare interoperability solutions market in 2021, followed by Europe and Asia Pacific. The rising demand for value-based healthcare, the need to reduce the increasing healthcare costs, and the implementation of favorable government initiatives & regulations in the region are the key factors responsible for the large share of North America in the healthcare interoperability solutions market.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=17705847

Healthcare Interoperability Solutions Market Dynamics:

Drivers:

1. Increasing demand for efficient and cost-effective healthcare delivery
2. Government initiatives and regulations to enhance patient care and safety
3. Emergence of new medical technologies
4. Growing adoption of electronic health records

Restraints:

1. Lack of accurate interoperability solutions across healthcare supply chain
2. Lack of standards and protocols in IT businesses
3. Use of outdated legacy systems in hospitals and clinic chains

Opportunities:

1. Growing markets for healthcare interoperability solutions in developing countries
2. Advancements in software technology for real-time data exchange

Challenges:

1. Increasing complexity due to lack of consistent data
2. Shortage of skilled healthcare IT professionals
3. Patient data security and privacy concerns in healthcare industry

Key Market Players:

Some of the prominent players in this market are Cerner Corporation (US), Epic Systems Corporation (US), Infor, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), IBM Watson Health (US), Lyniate (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), and Medical Information Technology, Inc. (US), iNTERFACEWARE (Canada), OSP Labs (US), ViSolve, Inc. (US), Jitterbit (US), Virtusa Corp. (US), and Summit Healthcare Services, Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=17705847

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/healthcare-interoperability-solution-market-17705847.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Healthcare Interoperability Solutions Market worth $6.2 billion by 2027 | MarketsandMarkets

“Transplant Diagnostics Market worth $6.8 billion | MarketsandMarkets”

Transplant Diagnostics Market in terms of revenue was estimated to be worth $4.4 billion in 2022 and is poised to reach $6.8 billion by 2028, growing at a CAGR of 7.4% from 2022 to 2028 according to a new report by MarketsandMarkets™. Organ transplants have gradually improved over the past 20 years and typically produce excellent results in children and young adults. However, the proportion of elderly transplant patients with comorbidities is increasing, posing a greater challenge. When compared to dialysis, renal transplants increase patient survival, and patients with liver, heart, or lung diseases that are incurable must receive life-saving transplants. The activity of solid organ transplant programmes has been steadily increasing, but it still falls short of global needs and varies greatly between nations. Transplanting solid organs is crucial for advanced and established medical systems.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061

Molecular assay technologies segment to register a significant growth rate over the forecast period of 2022-2028

Based on Technology, molecular assay technologies are segmented to witness the highest growth during the forecast period. Molecular assay technologies are segmented into PCR-Based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further segmented into Real-time PCR, Sequence-specific primer, Sequence-specific Oligonucleotide and other PCR-based molecular assays.

Sequence-specific Oligonucleotide is growing at the highest CAGR of 9.5%.

The Reagents & Consumables holds the largest share in the Product and Service segment of the Transplant diagnostic market.

The reagents and consumables is projected to reach USD 5,131.0 million from USD USD 3,265.2 million in 2022 with the CAGR of 7.8%.

Based on End users, the transplant diagnostic market is segmented into Hospitals and Diagnostic centers, Research & Academic Institutes and Independent reference laboratories. The Independent reference laboratories segment accounted for the largest share of the transplant diagnostic market. The growing number of organ transplant procedures and growing number of diagnostic labs across emerging countries are helping the independent diagnostic centers to hold the largest share.

North America to register major growth in the market during the forecast period

North America transplant diagnostic market is anticipated to register the highest growth over the forecast period of 2022 to 2028. North America accounted for the largest share of 45.5% of the transplant diagnostic market in 2022. This market is projected to reach USD 3.1 billion by 2028 from USD 2.0 billion in 2022, at a CAGR of 7.6% during the forecast period. North America holds 45.5% share of the total antimicrobial susceptibility testing market. The large share of North America can be attributed due to the growth in the geriatric population and the increase in infectious diseases., Asia-Pacific is expected to experience significant development.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=2531061

Transplant Diagnostics Market Dynamics:

Drivers:

1. Increasing number of transplant procedures
2. Technological advancements in transplant diagnostic procedures
3. Increasing public-private funding for target research activities
4. Rising prevalence of infectious diseases

Restraints:

1. High procedural cost of NGS- and PCR-based diagnostic assays
2. Limited reimbursement for target procedures

Opportunities:

1. Rising adoption of cross-matching and chimerism testing during pre- & post-transplantation
2. Growing public awareness about organ donation and transplantation

Challenges:

1. Significant gap between number of organ donors and organs required annually
2. Procedural and technical limitations associated with donor-recipient screening

Key Market Players:

As of 2022, prominent players are Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.F-Hoffman-LA-Roche, and Thermo fisher Scientific.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=2531061

Transplant Diagnostics Market Advantages:

• Transplant diagnostics allow for improved accuracy in the diagnosis and treatment of organ transplant recipients.
• More accurate diagnostic tests can lead to earlier detection and treatment of organ transplant complications, reducing the risk of organ rejection and other transplant-related complications.
• Improved accuracy can reduce health care costs by reducing the number of unnecessary treatments and tests.
• Transplant diagnostics can also help to identify the most suitable donor organs for transplantation, reducing the risk of organ rejection and improving the success rate of transplants.
• Transplant diagnostics can also help to improve the quality of life for transplant recipients by providing more accurate and timely diagnosis and treatment.

Transplant Diagnostics Market – Report Highlights:

• The study consists of the average selling price (ASP) analysis for different products in the Transplant Diagnostic market.
• The research study comprises the patent analysis of technologies/solutions used in the Transplant Diagnostic market
• The new market study consists of the trends/disruptions impacting customers’ businesses.
• The new market study consists of information on key conferences and events in 2022–2028.
• The new market study consists of the region-wise regulatory landscape.
• The new market study provides details of the strategies of the top 5 players operating in the market.
• The competitive landscape chapter has been updated with the market evaluation matrix. The competitive landscape also includes the market share analysis of major global players (as of 2021), updated competitive leadership mapping, and competitive situations and trends.
• The new market study comprises 25 players. These companies have emerged as key market players in recent years due to their products and various strategic investments undertaken in the transplant diagnostic market.
• Updated financial information/product portfolio of players: The new edition of the report provides updated financial information in the context of the medical aesthetic market from January 2020 to July 2022 (depending on availability) for each listed company in graphical representation.
• Updated market developments of profiled players: The current report includes the market developments from January 2022 to July 2022.

During the production cycle of the report, in-depth interviews were conducted with various primary respondents, which include key opinion leaders, subject matter experts, directors, and C-level executives of selected particle counters vendors to obtain and verify critical qualitative and quantitative information. This primary data was collected mainly through questionnaires, mails, and telephonic interviews.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Transplant Diagnostics Market Future Scope, Size, Share, Latest Trends, Growth Factors, Advance Technology And Forecast – 2028